blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3003308

EP3003308 - NEW DRUG FOR THE TREATMENT AND/OR PREVENTION OF DEPRESSIVE DISORDERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.08.2021
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  28.08.2020
FormerGrant of patent is intended
Status updated on  25.08.2020
FormerExamination is in progress
Status updated on  05.06.2020
FormerGrant of patent is intended
Status updated on  04.02.2020
FormerExamination is in progress
Status updated on  07.04.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Sorbonne Université
21, rue de L'École de Médecine
75006 Paris / FR
For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3 rue Michel-Ange
75794 Paris Cedex 16 / FR
For all designated states
Assistance Publique Hôpitaux de Paris
3, Avenue Victoria
75184 Paris Cedex 04 / FR
For all designated states
Université Paris Descartes
12, Rue de l'Ecole de Médecine
75006 Paris 6 / FR
[2020/40]
Former [2018/29]For all designated states
Sorbonne Universite
21 rue de L'École de Médecine
75006 Paris / FR
For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3 rue Michel-Ange
75794 Paris Cedex 16 / FR
For all designated states
Assistance Publique Hôpitaux de Paris
3, Avenue Victoria
75184 Paris Cedex 04 / FR
For all designated states
Université Paris Descartes
12, Rue de l'Ecole de Médecine
75006 Paris 6 / FR
Former [2016/15]For all designated states
Université Pierre et Marie Curie (Paris 6)
4, Place Jussieu
75005 Paris / FR
For all designated states
Centre National de la Recherche Scientifique (CNRS)
3, rue Michel-Ange
75794 Paris Cedex 16 / FR
For all designated states
Assistance Publique Hôpitaux de Paris
3, Avenue Victoria
75184 Paris Cedex 04 / FR
For all designated states
Université Paris Descartes
12, Rue de l'Ecole de Médecine
75006 Paris 6 / FR
Inventor(s)01 / BENOLIEL, Jean-Jacques
54 rue de Picpus
F-75012 Paris / FR
02 / BECKER, Christel
25 rue du Borrégo
F-75020 Paris / FR
03 / BOUVIER, Elodie
28 allée Louis Breguet
94310 Orly / FR
 [2016/15]
Representative(s)Grosset-Fournier, Chantal Catherine, et al
Grosset-Fournier & Demachy
54, rue Saint-Lazare
75009 Paris / FR
[2016/15]
Application number, filing date14728158.830.05.2014
[2016/15]
WO2014EP61240
Priority number, dateEP2013016993630.05.2013         Original published format: EP 13169936
[2016/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014191547
Date:04.12.2014
Language:EN
[2014/49]
Type: A1 Application with search report 
No.:EP3003308
Date:13.04.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 04.12.2014 takes the place of the publication of the European patent application.
[2016/15]
Type: B1 Patent specification 
No.:EP3003308
Date:30.09.2020
Language:EN
[2020/40]
Search report(s)International search report - published on:EP04.12.2014
ClassificationIPC:A61K31/445, A61P25/24
[2016/15]
CPC:
A61K31/445 (EP,US); A61K31/135 (EP,US); A61K31/138 (EP,US);
A61K31/15 (EP,US); A61K31/343 (EP,US); A61K31/381 (EP,US);
A61K31/5375 (EP,US); A61K31/55 (EP,US); A61K33/00 (EP,US);
A61K45/06 (EP,US); A61P25/24 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/135, A61K2300/00 (EP,US);
A61K31/138, A61K2300/00 (US,EP);
A61K31/15, A61K2300/00 (US,EP);
A61K31/343, A61K2300/00 (US,EP);
A61K31/381, A61K2300/00 (EP,US);
A61K31/445, A61K2300/00 (US,EP);
A61K31/5375, A61K2300/00 (EP,US);
A61K31/55, A61K2300/00 (EP,US);
A61K33/00, A61K2300/00 (EP,US)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/15]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NEUES ARZNEIMITTEL ZUR BEHANDLUNG UND/ODER VORBEUGUNG VON DEPRESSIONSERKRANKUNGEN[2016/15]
English:NEW DRUG FOR THE TREATMENT AND/OR PREVENTION OF DEPRESSIVE DISORDERS[2016/15]
French:NOUVEAU MÉDICAMENT POUR LE TRAITEMENT ET/OU LA PRÉVENTION DES TROUBLES DÉPRESSIFS[2019/47]
Former [2016/15]NOUVEAU MÉDICAMENT POUR LE TRAITEMENT ET/OU LA PRÉVENTION DE TROUBLES DÉPRESSIFS
Entry into regional phase02.11.2015National basic fee paid 
02.11.2015Designation fee(s) paid 
02.11.2015Examination fee paid 
Examination procedure02.11.2015Examination requested  [2016/15]
05.07.2016Amendment by applicant (claims and/or description)
06.04.2017Despatch of a communication from the examining division (Time limit: M07)
13.11.2017Reply to a communication from the examining division
30.10.2018Despatch of a communication from the examining division (Time limit: M04)
26.02.2019Reply to a communication from the examining division
05.02.2020Communication of intention to grant the patent
02.06.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
02.06.2020Receipt of the translation of the claim(s)
05.06.2020Fee for grant paid
05.06.2020Fee for publishing/printing paid
25.08.2020Information about intention to grant a patent
25.08.2020Receipt of the translation of the claim(s)
Opposition(s)01.07.2021No opposition filed within time limit [2021/36]
Fees paidRenewal fee
31.05.2016Renewal fee patent year 03
31.05.2017Renewal fee patent year 04
31.05.2018Renewal fee patent year 05
31.05.2019Renewal fee patent year 06
29.05.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.05.2014
AL30.09.2020
AT30.09.2020
CY30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
MK30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
GB30.05.2021
IE30.05.2021
LU30.05.2021
BE31.05.2021
CH31.05.2021
FR31.05.2021
LI31.05.2021
[2024/22]
Former [2023/30]HU30.05.2014
AL30.09.2020
AT30.09.2020
CY30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
GB30.05.2021
IE30.05.2021
LU30.05.2021
BE31.05.2021
CH31.05.2021
FR31.05.2021
LI31.05.2021
Former [2023/29]HU30.05.2014
AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
GB30.05.2021
IE30.05.2021
LU30.05.2021
BE31.05.2021
CH31.05.2021
FR31.05.2021
LI31.05.2021
Former [2022/34]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
GB30.05.2021
IE30.05.2021
LU30.05.2021
BE31.05.2021
CH31.05.2021
FR31.05.2021
LI31.05.2021
Former [2022/23]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
GB30.05.2021
IE30.05.2021
LU30.05.2021
CH31.05.2021
FR31.05.2021
LI31.05.2021
Former [2022/22]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
PT01.02.2021
GB30.05.2021
IE30.05.2021
LU30.05.2021
CH31.05.2021
LI31.05.2021
Former [2022/21]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
PT01.02.2021
IE30.05.2021
LU30.05.2021
CH31.05.2021
LI31.05.2021
Former [2022/10]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
PT01.02.2021
LU30.05.2021
CH31.05.2021
LI31.05.2021
Former [2022/09]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
LU30.05.2021
Former [2022/07]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/50]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/48]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/37]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/28]AL30.09.2020
AT30.09.2020
CZ30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/25]AL30.09.2020
AT30.09.2020
CZ30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/24]AT30.09.2020
CZ30.09.2020
EE30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
PT01.02.2021
Former [2021/23]CZ30.09.2020
EE30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
PT01.02.2021
Former [2021/22]CZ30.09.2020
EE30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
PT01.02.2021
Former [2021/21]FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
RS30.09.2020
SE30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
PT01.02.2021
Former [2021/20]FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
RS30.09.2020
SE30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
Former [2021/10]FI30.09.2020
HR30.09.2020
LV30.09.2020
RS30.09.2020
SE30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
Former [2021/08]FI30.09.2020
SE30.09.2020
BG30.12.2020
NO30.12.2020
Former [2021/07]FI30.09.2020
NO30.12.2020
Cited inInternational search[XI]WO2004111021  (BTG INT LTD [GB], et al) [X] 1 * examples 6,7,8,12,13 * [I] 2-15;
 [AD]US2012115905  (PROCTOR PETER HERBER [US]) [AD] 1-15 * paragraph [0115] *;
 [XI]  - FEDOCE A ET AL, "Systemic administration of tempol, an antioxidant agent, attenuates the increased conditioned emotional response induced by restraint-stress", SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, & 42ND ANNUAL MEETING OF THE SOCIETY-FOR-NEUROSCIENCE; NEW ORLEANS, LA, USA; OCTOBER 13 -17, 2012, (2012), vol. 42, XP009170718 [X] 1,4-10 * the whole document * [I] 2,3,11-15
 [I]  - ROBERT D. ROGHAIR ET AL, "Maternal antioxidant blocks programmed cardiovascular and behavioural stress responses in adult mice", CLINICAL SCIENCE, (20110725), vol. 7, no. 10, doi:10.1371/journal.pone.0009250, ISSN 0143-5221, pages 265 - 436, XP055126039 [I] 1-15 * figure 1 *

DOI:   http://dx.doi.org/10.1042/CS20110153
ExaminationWO0130352
 WO2009147681
    - A Teichner ET AL, "Combination of dexanabinol and tempol in focal cerebral ischemia: is there a ceiling effect?", Experimental Neurology, AMSTERDAM, NL, (20030801), vol. 182, no. 2, doi:10.1016/S0014-4886(03)00083-9, ISSN 0014-4886, pages 353 - 360, XP055471646

DOI:   http://dx.doi.org/10.1016/S0014-4886(03)00083-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.